LHDX - Lucira Health to Participate in Upcoming BofA Securities 2021 Virtual Healthcare Conference
EMERYVILLE, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will be participating in the BofA Securities 2021 Virtual Healthcare Conference.
Lucira Health’s management is scheduled to participate in the conference on Thursday, May 13, 2021, at 9:30 a.m. PT / 12:30 p.m. ET. A live and archived webcast of the event can be accessed via the Investors page of the investor section of Lucira's website.
About Lucira Health
Lucira Health is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira’s testing platform produces lab quality molecular testing in a single-use, consumer-friendly, palm size test kit powered by two AA batteries. Lucira designed its test kits to provide accurate, reliable and on-the-spot molecular tests results anywhere and anytime. The LUCIRA CHECK IT (OTC) and LUCIRA COVID-19 All-In-One Test Kits (RX) are designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection. For more information, visit www.lucirahealth.com .
Investor Contact
Greg Chodaczek
Investorrelations@lucirahealth.com
347-620-7010
Media Contact
Kevin Knight
media@lucirahealth.com
206-451-4823